You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epstein-Barr Virus Infections

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

Not yet recruiting
  • Adenovirus
  • +2 more
  • Specific T- Lymphocytes
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Sep 8, 2023

Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))

Enrolling by invitation
  • Multiple Sclerosis
  • Truvada (tenofovir/emtricitabine)
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 14, 2023

Study on Infectious Mononucleosis in Munich

Completed
  • Infectious Mononucleosis
  • Epstein-Barr Virus Infections
    • Munich, Bavaria, Germany
      MRI Chonic Fatigue Center for Young People (MCFC), Children's Ho
    Aug 16, 2023

    Early Detection of Epstein-Barr Virus Related Disease.

    Active, not recruiting
    • Post-transplant Lymphoproliferative Disorder
    • +8 more
      • Aarhus, Central Region Of Denmark, Denmark
        Aarhus University Hospital
      Dec 12, 2022

      Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder Trial run by the NCI (Nivolumab)

      Recruiting
      • Epstein-Barr Virus Infections
      • +3 more
      • Nivolumab
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 24, 2023

      Epstein Barr Virus Infection in Radiologically Isolated Syndrome

      Recruiting
      • Multiple Sclerosis
      • +2 more
      • NO INTERVENTION
      • Nice, France
        Nice University Hospital
      Apr 3, 2023

      Genetic Studies of Chronic Active Epstein-Barr Disease

      Recruiting
      • Chronic Active Epstein-Barr Virus
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

        Recruiting
        • Secondary Hemophagocytic Lymphohistiocytosis
        • Chronic Active Epstein-Barr Virus Infection
        • No intervention
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        May 2, 2023

        PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

        Not yet recruiting
        • PD-1 Antibody
        • +3 more
        • L-DEP and PD-1 antibody
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Mar 8, 2023

        CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

        Not yet recruiting
        • CMV Infection
        • +2 more
        • Virus specific T cells
        • (no location specified)
        Oct 4, 2023

        Segmental Resection Combined With DEP Regimen for EBV-HLH

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytosis
        • +2 more
        • Segmental bowel resection combined with the DEP regimen
        • Beijing, Beijing, China
          Zhao Wang
        Nov 9, 2023

        Immunodeficiency for Severe Epstein-Barr Virus Infection

        Recruiting
        • Epstein-Barr Virus Infections
        • Immunodeficiency
          • Shanghai, Shanghai, China
            Children's Hospital of Fudan University
          Mar 21, 2022

          Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus Trial run by the National Institute of Allergy and

          Not yet recruiting
          • Epstein-Barr Virus Infection
          • +2 more
          • Matrix-M1 Adjuvant
          • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Feb 2, 2023

          Epstein-Barr Virus Infection moniToring in renAl Transplant

          Recruiting
          • EBV Infection
          • +3 more
          • EBV DNA in whole blood and plasma
          • Aarhus, Central Region Denmark, Denmark
          • +2 more
          Dec 12, 2022

          Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection Trial in Beijing (Rituximab

          Recruiting
          • Secondary Hemophagocytic Lymphohistiocytosis
          • Chronic Active Epstein-Barr Virus Infection
          • Rituximab Monotherapy
          • Beijing, China
            Zhao Wang
          May 18, 2022

          Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial

          Not yet recruiting
          • Adenocarcinoma of the Stomach
          • +2 more
          • Hangzhou, Zhejiang, China
          • +7 more
          Jul 25, 2023

          ME/CFS, SARS CoV 2 Infection, Fatigue Syndrome, Chronic Trial in München

          Recruiting
          • ME/CFS
          • +3 more
            • München, Germany
              München Klinik Schwabing
            Mar 20, 2023

            Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for

            Recruiting
            • Nasopharyngeal Carcinoma
            • EBV antibodies test
            • EBV DNA test
            • Guangzhou, Guangdong, China
              Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
            Jul 6, 2022

            Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

            Active, not recruiting
            • Acute Lymphocytic Leukemia
            • Lymphoma
            • Biological/Genetically Modified T cells
            • Cyclophosphamide-based chemotherapy
            • New York, New York
              Memorial Sloan Kettering Cancer Center
            Jan 3, 2023

            Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Singapore (FDG-PET, Galium-68 DOTATATE)

            Recruiting
            • Nasopharyngeal Cancer
            • Epstein-Barr Virus Related Carcinoma
            • FDG-PET
            • Galium-68 DOTATATE
            • Singapore, Singapore
              National Cancer Centre Singapore
            Oct 13, 2022

            Verification of Harmonization of Plasma Epstein-Barr Virus DNA

            Recruiting
            • Nasopharyngeal Carcinoma
            • Plasma EBV DNA qPCR test
            • Guangzhou, Guangdong, China
              Sun Yat-sen University Cancer Center
            Jul 3, 2022

            Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

            Recruiting
            • Epstein-Barr Virus Infections
            • Primary Immune Deficiency Disorder
            • cytotoxic t-lymphocytes
            • Los Angeles, California
            • +7 more
            Sep 27, 2022

            EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

            Recruiting
            • EBV Infection After Allogenic HSCT
            • EBV-TCR-T cells
            • Beijing, Beijing, China
              Chinese PLA General Hospital
            Nov 3, 2023

            EBV, Epstein-Barr Virus Infection, Infectious Mononucleosis Trial run by the NIAID (EBV gp350-Ferritin Vaccine, Matrix-M1)

            Recruiting
            • EBV
            • +2 more
            • EBV gp350-Ferritin Vaccine
            • Matrix-M1
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jul 11, 2022

            EBV Infection Trial in Belgium (2LEBV® / 2LXFS®, Placebo)

            Recruiting
            • EBV Infection
            • 2LEBV® / 2LXFS®
            • Placebo
            • Aartselaar, Belgium
            • +12 more
            Dec 22, 2022